CLGN•benzinga•
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Lowers Price Target to $12
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 28, 2025 by benzinga